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 INTRODUCTION
 Chronic pancreatitis (CP), a chronic infl ammatory disorder 
of the pancreas, is characterized by irreversible morpho-
logical changes of the pancreas, abdominal pain—which is 
oft en chronic and debilitating, episode(s) of acute pancreati-
tis (AP), impairment of endocrine and exocrine function, and 
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 OBJECTIVES:  Chronic pancreatitis (CP) has a profound independent effect on quality of life (QOL). Our aim was to 
identify factors that impact the QOL in CP patients.
 METHODS:  We used data on 1,024 CP patients enrolled in the three NAPS2 studies. Information on 
demographics, risk factors, co-morbidities, disease phenotype, and treatments was obtained from 
responses to structured questionnaires. Physical and mental component summary (PCS and MCS, 
respectively) scores generated using responses to the Short Form-12 (SF-12) survey were used to 
assess QOL at enrollment. Multivariable linear regression models determined independent predictors 
of QOL.
 RESULTS:  Mean PCS and MCS scores were 36.7±11.7 and 42.4±12.2, respectively. Signiﬁ cant ( P <0.05) 
negative impact on PCS scores in multivariable analyses was noted owing to constant mild–moderate 
pain with episodes of severe pain or constant severe pain (10 points), constant mild–moderate 
pain (5.2), pain-related disability/unemployment (5.1), current smoking (2.9 points), and medical 
co-morbidities. Signiﬁ cant ( P <0.05) negative impact on MCS scores was related to constant pain 
irrespective of severity (6.8–6.9 points), current smoking (3.9 points), and pain-related disability/
unemployment (2.4 points). In women, disability/unemployment resulted in an additional 3.7 point 
reduction in MCS score. Final multivariable models explained 27% and 18% of the variance in 
PCS and MCS scores, respectively. Etiology, disease duration, pancreatic morphology, diabetes, 
exocrine insufﬁ ciency, and prior endotherapy/pancreatic surgery had no signiﬁ cant independent 
effect on QOL.
 CONCLUSIONS:  Constant pain, pain-related disability/unemployment, current smoking, and concurrent co-morbidities 
signiﬁ cantly affect the QOL in CP. Further research is needed to identify factors impacting QOL not 
explained by our analyses.
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in a small subset of patients, development of pancreatic 
cancer ( 1 ).
 In previous single-center studies, quality of life (QOL) in 
patients with CP was noted to be signifi cantly impaired when 
compared with historical population controls ( 2,3 ). In a large, 
multicenter study, we demonstrated a profound eff ect of CP on 
physical and a modest eff ect on mental QOL when compared with 
subjects without pancreatitis, independent of demographics, risk 
factors, etiology, and common medical conditions ( 4 ). Although 
these data document the poor QOL in CP patients, they do not 
provide an explanation for the factors responsible for this obser-
vation. Understanding these factors is of importance in the clini-
cal management of patients, especially if they can be modifi ed by 
behavioral changes, treatment of disease, or its complications.
 Studies evaluating independent factors associated with low 
QOL in CP patients have consistently reported abdominal pain to 
be an important predictor ( 3,5–10 ). Treatment of pain by surgical 
or endoscopic therapy has documented eff ect not only in achiev-
ing pain relief but also in improving QOL ( 11–14 ). Etiology of CP 
has not been found to aff ect QOL ( 3,5,8 ). Younger age, female sex, 
smoking, alcohol consumption, low body mass index, diabetes, 
exocrine pancreatic insuffi  ciency, pancreatic morphology, and dis-
ease duration lower QOL, but their association has been inconsist-
ent across studies ( 3,5,7,8,10 ). Th e reasons for this inconsistency 
include variability in the instruments used to determine QOL, 
small sample size of studies, and the lack of use of uniform predic-
tor variables. Th e eff ect of pain-related disability or unemployment 
on QOL has not been adequately studied.
 Th e North American Pancreatitis Study 2 (NAPS2) studies have 
prospectively ascertained over 1,000 well-phenotyped patients 
with CP from several US centers. Systematically collected data on 
QOL and several potential predictor variables provided us with an 
opportunity to determine which factors may aff ect QOL in this 
cohort.
 METHODS
 Study population
 We utilized data from the NAPS2 studies for this analysis. NAPS2 
consists of a series of three studies (original NAPS2, NAPS2-CV, 
and NAPS2-AS) from 27 centers in the United States that pro-
spectively ascertained 1,195 CP, 569 recurrent AP and 1,109 con-
trols from 2000 to 2014. One of the participating centers only 
enrolled control subjects. Detailed methodology for the NAPS2 
studies has been published ( 15–17 ). CP was defi ned by defi nitive 
changes on imaging studies (primarily endoscopic retrograde 
cholangiopancreatography or computed tomography scan or 
equivalent changes on magnetic resonance cholangiopancrea-
tography or endoscopic ultrasound) or histology. Th e study was 
approved by the Institutional Review Board of each center and all 
subjects provided written informed consent prior to enrollment.
 Th e present study includes 1,024/1,195 (85.6%) CP patients 
from the three NAPS2 studies who provided complete responses 
for determination of QOL, disability/unemployment, and pain 
characteristics (pain pattern and severity).
 Data collection
 Study subjects completed a detailed questionnaire, including 
information on demographics, family and personal history, 
exposure to smoking and alcohol, pain experience, disability/
unemployment related to pain from pancreatitis, and QOL. Self-
reported alcohol use during the maximum drinking period of 
life was used to create drinking categories (abstainers: no alco-
hol use or <20 drinks in a lifetime; light drinkers: ≤3 drinks per 
week; moderate drinkers: 4–7 drinks per week for females and 
4–14 drinks per week for males; heavy drinkers: 8–34 drinks 
per week for females and 15–34 drinks per week for males; very 
heavy drinkers: ≥35 drinks per week for both sexes) and smok-
ing (status: never, past, current; amount: <1 packs per day or ≥1 
packs per day; and <12, 12–35, and ≥35 pack-years) as described 
previously ( 15 ).
 Th e enrolling physician investigator completed a separate ques-
tionnaire consisting of information on etiology, TIGAR-O ((i) 
Toxic-metabolic (ii) Idiopathic (iii) Genetic (iv) Autoimmune (v) 
Recurrent and severe AP or (vi) obstructive) risk factors, pheno-
typic characteristics (history of AP, age at AP, age at the onset of 
CP symptoms, age at CP diagnosis, presence of diabetes, exocrine 
insuffi  ciency, imaging features), and treatments received (medica-
tions, surgical and endoscopic interventions), and their perceived 
eff ectiveness.
 QOL evaluation
 Th e Short Form-12 (SF-12) version 2 was used to assess QOL in 
the NAPS2-CV and NAPS2-AS studies. In the original NAPS2 
study, QOL was assessed using the SF-12 version 1, and scores 
were transformed to version 2 for interpretation ( 18 ). SF-12 is a 
multipurpose generic QOL questionnaire that was derived from 
the SF-36 Health Survey ( 18,19 ). Th e SF-36 and SF-12 have been 
validated in several languages and disease conditions, including 
CP ( 2,3,20 ). Th e SF-12 is comprised of 12 questions that measure 
8 domains (role physical, role emotional, physical function, social 
function, mental health, vitality, bodily pain, and general health) 
and can be summarized into the physical component summary 
(PCS) and mental component summary (MCS) scores. SF-12 
questionnaire takes approximately 2 min to complete without a 
signifi cant loss of information and is based on a standard recall 
of 4 weeks ( 18 ). Th e summary scores for each domain are then 
transformed to  z -scores using the SF-12 scale means and s.d. from 
the 1998 general US population to produce a normally distributed 
population score. PCS and MCS scores range from 0 to 100 with a 
score of 50±10 representing the mean±s.d. for the general popu-
lation. Th ese scores provide a direct comparison of the distribu-
tion in the population of interest when compared with the general 
population and between groups. A diff erence of three points in 
the PSC or MCS scores between groups has been suggested to be 
clinically relevant ( 4 ).
 Pain and disability/unemployment assessment
 We used patient-reported pain experience for all comparisons 
in this study. In the NAPS2-CV and NAPS2-AS studies, there 
was a leading question on the presence of pain (i.e., Have you 
© 2017 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
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experienced abdominal pain related to pancreatitis in the past 
year?). Patients who reported “yes” were asked to choose from 
one of the fi ve predefi ned pain patterns (episodes of mild-to-
moderate pain; constant mild-to-moderate pain; usually pain free 
with episodes of severe pain; constant mild pain plus episodes of 
severe pain; and constant severe pain that does not change). For 
this study, we incorporated the presence, severity, and temporal 
nature of pain to classify patients into the following fi ve catego-
ries: (i) No pain; (ii) Intermittent mild-to-moderate episodes of 
pain; (iii) Intermittent severe episodes of pain; (iv) Constant 
mild-to-moderate pain; and (v) Constant mild-to-moderate pain 
with episodes of severe pain or constant severe pain that does not 
change. In the original NAPS2 study, a leading question on the 
presence of pain was not asked and patients were directly asked 
to complete the question in the fi ve pain patterns ( 15 ). Th erefore, 
patients in the original NAPS2 study who did not identify with a 
pain pattern were excluded from the fi nal analysis ( n =126) as it is 
impossible to distinguish those patients without pain and those 
with pain who simply left  their pain category blank. In addition, 
patients from the three NAPS2 studies were asked for the pres-
ence of pain-related disability or unemployment.
 Statistics
 Th e PCS and MCS scores were computed using the scoring 
method system provided in the SF-12 version 2 reference manual 
and presented as mean±s.d. ( 18 ). Descriptive analyses are pre-
sented as proportions for categorical data and as mean±s.d. for 
continuous data. Comparison between the PCS and MCS scores 
within each group variable was carried out using Kruskal–Wal-
lis test. All variables with a  P -value of <0.2 on univariate analysis 
comparing the PCS and MCS scores were considered for potential 
inclusion in the multivariable models.
 Multivariable linear regression models were used to deter-
mine the independent predictors of physical and mental QOL. 
A backwards selection technique was used to determine signifi -
cant independent predictors. Age and gender were included in 
both fi nal models because of clinical signifi cance. Other vari-
ables were removed one by one in order of the magnitude of the 
 P -value for the type III F-test, with the exception of diabetes which 
was removed from the PCS model owing to its small eff ect size 
compared with the other variables remaining. Models were then 
re-run until a fi nal model was reached containing only the vari-
ables with  P <0.05. For the MCS fi nal model, history of liver disease 
was borderline signifi cant and was included in the fi nal model. 
Th ere were missing data in some variables, but in no case did they 
exceed ~6%. Th e PCS model was not examined for interactions 
to maintain easier interpretation and out of concern of including 
too many variables in the fi nal model. Signifi cant interactions were 
examined for the MCS model. For easier interpretation, the fi nal 
models were centered at the age of 50 years. As the original NAPS2 
study used an earlier version of SF12 and the presence of pain 
was not assessed by a leading question, a sensitivity analysis was 
performed aft er excluding these patients and using the same vari-
ables included in the fi nal models. Data analysis was performed 
using SAS version 9.4 (SAS Institute Inc., Cary, NC).
 RESULTS
 Demographics, risk factors, and clinical characteristics
 Of the 1,024 CP patients who formed the fi nal study cohort, 381 
(37.2%) were enrolled in the original-NAPS2 study, 510 (49.8%) 
in the NAPS2-CV study, and 133 (13.0%) in the NAPS2-AS study. 
Th e distribution of baseline socio-demographic and clinical char-
acteristics is shown in  Table 1 .
 Overall, patients had a mean age of 50.4±14.6 years, 54.6% were 
male, 74.8% were white, 19.6% were current drinkers, and the 
majority had a normal/low body mass index (57.6%). Heavy or 
very heavy drinking during the maximum drinking period of life 
was reported by 15.1% and 34.9% and past or current smoking by 
25.3% and 50.1% patients, respectively. Physicians considered alco-
hol as the main etiological factor in about half of (50.2%) patients. 
In >50% patients (54.6%), the duration of CP was ≥4 years.
 In our fi nal study cohort, abdominal pain in the year preced-
ing enrollment was present in 91.6%. Th e most common pattern 
of abdominal pain identifi ed was constant mild-to-moderate pain 
with episodes of severe pain or constant severe pain (48.5%). Less 
frequently patients identifi ed intermittent episodes of severe pain 
(24%), intermittent episodes of mild-to-moderate pain (12.8%), 
and constant mild-to-moderate pain (6.3%). Pain-related dis-
ability/unemployment was reported by 27.1% of patients. About 
one-third of patients had exocrine insuffi  ciency (38.1%) or diabe-
tes (33.1%). Although 40.3% received only medical management, 
a prior history of pancreatic endotherapy was noted in 37.7% and 
pancreatic surgery in 21.5% patients. Almost half of the patients 
(44.3%) had history of gallstones or cholecystectomy. Th e most 
commonly reported co-morbidities noted were heart disease/heart 
attack/stroke (11.8%), liver disease (9%), renal disease (6.1%), or 
prior history of cancer (3.7%).
 Predictors of physical QOL
 Univariable analysis .  Mean PCS score for the study cohort was 
36.7±11.7. Univariable analysis for PCS scores based on demo-
graphics, risk factors, and clinical characteristics are shown in 
 Table 1 . A signifi cantly lower physical QOL was noted with 
younger age, female sex, black race, extremes of alcohol con-
sumption, current smoking, disability/unemployment, pain, and 
diabetes. A medical history of heart disease/heart attack/stroke, 
cancer, liver disease, renal disease, gallstones, or cholecystectomy 
was also signifi cantly associated with lower PCS scores. Interest-
ingly, the association was only borderline with disease duration, 
and no association was noted with body mass index, etiology, exo-
crine insuffi  ciency, pancreatic morphology, prior endotherapy, or 
pancreatic surgery.
 Multivariable analysis .  Results for multivariable regression anal-
yses for physical QOL are shown in  Table 2 . Temporal nature and 
severity of pain had the greatest impact on physical QOL. Com-
pared with patients with no pain, constant mild-to-moderate pain 
with episodes of severe pain or constant severe pain reduced the 
PCS score by 10 points, while constant mild-to-moderate pain 
alone decreased it by 5.2 points. Presence of severe pain that was 
intermittent was also important but the impact of this (2.6 points) 
The American Journal of GASTROENTEROLOGY    www.nature.com/ajg
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 Table 1 .  Predictors of physical and mental QOL for CP patients in the NAPS2 study 
 Variable ( n =1,024)  N  (%)  Physical QOL score  Mental QOL score 
   Mean±s.d.  P -value  Mean±s.d.  P -value 
 Study type 
 NAPS2-Original  381 (37.2)  37.4±11.2  0.07  43.4±11.6  0.06 
 NAPS2-CV  510 (49.8)  36.9±12.1   42.2±12.7  
 NAPS2-AS  133 (13.0)  34.5±10.9   40.6±11.9  
 Age, years 
 <45  344 (33.5)  36.5±11.3  <0.001  41.1±12.2  <0.001 
 45–60  427 (41.7)  35.6±11.5   40.7±11.9  
 >60  253 (24.8)  39.1±12.2   47.2±11.7  
 Gender 
 Male  559 (54.6)  37.5±12.0  0.02  42.9±12.1  0.15 
 Female  465 (45.4)  35.8±11.2   41.8±12.3  
 Race (n=1,023) 
 Black  228 (22.3)  35.0±11.2  0.06  40.9±12.0  0.03 
 Caucasian  765 (74.8)  36.2±10.8   43.0±12.3  
 Other  30 (2.9)  37.2±11.8   40.6±12.4  
 Body mass index (n=1,017) 
 Normal/low  586 (57.6)  36.5±11.7  0.5  42.5±12.4  0.8 
 Overweight  275 (27)  37.4±11.9   42.1±12.2  
 Obese  156 (15.4)  36.1±11.1   42.6±11.8  
 Smoking (n=1,022) 
 Never  251 (24.6)  39.2±12.0  <0.001  45.1±10.7  <0.001 
 Past  259 (25.3)  38.5±12.1   45.1±11.6  
 Current  512 (50.1)  34.6±10.9   39.7±12.6  
 Current drinking 
 Yes  201 (19.6)  39.0±12.3  0.003  43.7±12.0  0.1 
 No  823 (80.4)  36.2±11.4   42.1±12.3  
 Drinking category (n=998) 
 Abstainer  171 (17.1)  35.5±11.0  <0.001  43.2±12.1  <0.001 
 Light  170 (17.0)  37.4±11.6   44.9±11.7  
 Moderate  159 (15.9)  40.2±12.2   44.2±11.2  
 Heavy  151 (15.1)  37.2±12.0   42.2±12.0  
 Very heavy  347 (34.9)  35.3±11.4   40.0±12.6  
 Alcohol etiology 
 Yes  510 (49.8)  36.0±11.2  0.06  40.9±12.3  <0.001 
 No  513 (50.2)  37.4±12.1   44.0±12.0  
 Disease duration, years (n=968) 
 ≤1  103 (10.7)  37.4±12.6  0.06  45.1±11.6  0.008 
 1–<2  122 (12.6)  38.2±12.5   43.9±12.9  
 2–<3  117 (12.1)  35.8±11.3   40.9±12.4  
 3–<4  97 (10.0)  39.5±11.1   40.3±12.8  
 ≥4  529 (54.6)  36.2±11.4   42.2±11.9  
 Pain pattern 
 No pain  86 (8.4)  43.7±11.9  <0.001  48.7±11.8  <0.001 
Table 1 continued on following page
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 Table 1 .  Continued 
 Variable ( n =1,024)  N  (%)  Physical QOL score  Mental QOL score 
   Mean±s.d.  P -value  Mean±s.d.  P -value 
 Intermittent mild-to-moderate episodes of pain  131 (12.8)  43.0±11.1   46.1±11.1  
 Intermittent severe episodes of pain  246 (24.0)  40.6±11.2   47.0±10.8  
 Constant mild-to-moderate pain  64 (6.3)  37.2±10.7   39.3±10.7  
  Constant mild-to-moderate pain with episodes of severe pain 
or constant severe pain 
 497 (48.5)  31.9±9.9   38.5±11.9  
 Disability/unemployment 
 Yes  277 (27.1)  30.6±8.6  <0.001  37.1±12.1  <0.001 
 No  747 (72.9)  39.0±11.8   44.4±11.7  
 Exocrine insufﬁ ciency 
 Yes  390 (38.1)  36.1±12.0  0.11  41.5±12.3  0.05 
 No  634 (61.9)  37.2±11.5   43.0±12.2  
 Endocrine insufﬁ ciency 
 Yes  339 (33.1)  35.3±11.9  0.004  41.9±12.1  0.2 
 No  685 (66.9)  37.5±11.5   42.7±12.3  
 Pseudocysts 
 Yes  309 (30.2)  36.0±11.6  0.12  41.4±12.4  0.06 
 No  715 (69.8)  37.1±11.7   42.9±12.1  
 Pancreatic surgery 
 Yes  210 (21.5)  35.8±11.5  0.12  41.6±11.8  0.19 
 No  814 (79.5)  37.0±11.7   42.7±12.3  
 Endoscopic therapy 
 Pancreatic endotherapy  386 (37.7)  36.2±11.0  0.58  41.9±11.9  0.31 
 Other endotherapy  126 (12.3)  36.9±12.3   43.9±11.7  
 None  512 (50.0)  37.1±12.0   42.5±12.6  
 History of heart disease/heart attack/stroke 
 Yes  121 (11.8)  32.9±11.2  <0.001  42.4±13.2  0.9 
 No  903 (88.2)  37.3±11.6   42.4±12.1  
 History of cancer 
 Yes  38 (3.7)  32.7±10.3  0.03  41.5±13.4  0.7 
 No  986 (96.3)  36.9±11.7   42.5±12.2  
 History of liver disease 
 Yes  92 (9.0)  33.3±10.7  0.002  39.6±12.0  0.03 
 No  932 (91.0)  37.1±11.7   42.7±12.2  
 History of gallstones/cholecystectomy 
 Yes  454 (44.3)  35.4±11.1  0.002  42.3±11.8  0.6 
 No  570 (55.7)  37.8±12.0   42.6±12.5  
 History of renal disease 
 Yes  62 (6.1)  33.3±10.7  0.02  41.8±11.5  0.6 
 No  962 (93.9)  37.0±11.7   42.5±12.3  
 CP, chronic pancreatitis; NAPS2, North American Pancreatitis Study 2; QOL, quality of life. 
 Numbers are provided in parenthesis for variables where the number of patients was less than the total sample size. 
 Body mass index categories: Normal/low—≤25 kg/m 2 ; Overweight—>25–≤30 kg/m 2 ; Obese—>30 kg/m 2 . 
 Drinking category deﬁ nition: Abstainers: no alcohol use or <20 drinks in a lifetime; Light drinkers:≤3 drinks/week; Moderate drinkers: 4–7 drinks/week for females, 
4–14 drinks/week for males; Heavy drinkers: 8–34 drinks/week for females, 15–34 drinks/week for males; Very heavy drinkers:≥35 drinks/week for both sexes. 
The American Journal of GASTROENTEROLOGY    www.nature.com/ajg
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of co-morbid conditions also had a signifi cant negative impact—a 
history of cancer, heart disease/heart attack/stroke, and renal fail-
ure reduced the PCS score by 4.4, 3.3, and 2.8 points, respectively. 
Other factors associated with lower PCS scores on the univariable 
analysis were not signifi cant aft er adjusting for other variables and 
were not included in the fi nal regression model. Variables in the 
fi nal multivariable model explained 27% of the variance in PCS.
 To illustrate the impact of individual factors and incremental 
eff ect of predictive factors, representative PCS score for a 50-year-
old man with CP and progressive addition of select attributes are 
shown in  Figure 1 . By adding constant mild-to-moderate pain with 
episodes of severe pain or constant severe pain, current smoking, 
and pain-related disability/unemployment, the PCS score would 
decrease from 45.8 to 27.8.
 Predictors of mental QOL
 Univariable analysis .  Th e mean MCS score for the study cohort 
was 42.4±12.2. Univariable analysis for MCS scores based on 
demographics, risk factors, and clinical characteristics is shown 
in  Table 1 . A signifi cantly lower mental QOL was noted with 
younger age, very heavy drinking, current smoking, disability/
unemployment, and pain. In contrast to physical QOL, mental 
QOL was signifi cantly lower in patients with physician-defi ned 
alcohol etiology and the duration of disease. Race, presence of 
pseudocysts, and exocrine insuffi  ciency showed borderline as-
sociation with MCS score, while sex, body mass index, diabetes, 
other features on pancreatic morphology, and prior endotherapy 
or pancreatic surgery showed no association.
 Multivariable analysis .  Th e results of multivariable regression 
analyses for mental QOL are shown in  Table 3 . Similar to physical 
QOL, presence of pain had the most impact on mental QOL. 
Interestingly, compared with those patients with no pain, a 
negative impact was seen only for constant pain irrespective of 
its severity. Th e impact of constant mild-to-moderate pain 
(6.8 points) was almost similar to constant mild-to-moderate 
pain with episodes of severe pain or constant severe pain (6.9 
points). Intermittent pain irrespective of severity did not signifi -
was less than constant pain. Moreover, a history of gallstones or 
cholecystectomy, which likely refl ects an indirect impact of pain, 
also had a negative impact (1.6 points). Other disease-related fac-
tors with a negative impact included disability/unemployment 
(5.1 points) and current smoking (2.9 points). Th e eff ect of self-
reported drinking history was interesting in that, when compared 
with lifetime abstainers, the PCS score was signifi cantly higher in 
patients who reported moderate (4.3 points) or heavy (2.5 points) 
drinking during their heaviest period of drinking in life. Presence 
 Table 2 .  Multivariable regression model showing signiﬁ cant 
determinants for physical quality of life in chronic pancreatitis 
 Variable  Reference 
category 
 Parameter 
estimate 
 s.e.  P -value 
 Intercept  —  45.8  1.5  <0.001 
 Age 50 years a  —  −0.04  0.02  0.1 
 Female  Male  −1.2  0.7  0.09 
 Pain 
  Intermittent 
mild-to-moderate 
episodes of pain 
 No pain  −0.8  1.5  0.6 
  Intermittent severe 
episodes of pain 
  −2.6  1.4  0.05 
  Constant mild-
to-moderate pain 
  −5.2  1.8  0.003 
  Constant mild-to-
moderate pain with 
episodes of severe 
pain or constant 
severe pain 
  −10  1.3  <0.001 
 Disabled or 
unemployed 
 Not disabled or 
unemployed 
 −5.1  0.8  <0.001 
 Smoking status 
 Past  Never smoker  −1  0.9  0.3 
 Current   −2.9  0.9  0.002 
 Drinking category 
 Light  Abstainer  2.1  1.1  0.06 
 Moderate   4.3  1.2  <0.001 
 Heavy   2.5  1.2  0.04 
 Very heavy   1.6  1.1  0.2 
 History of cancer  No cancer  −4.4  1.7  0.01 
 History of heart 
disease/heart 
attack/stroke 
 No heart 
disease/heart 
attack/stroke 
 −3.3  1  0.001 
 History of renal failure  No renal failure  −2.8  1.4  0.04 
 History of gallstones/
cholecystectomy 
 No gallbladder 
disease/chole-
cystectomy 
 −1.6  0.7  0.02 
 R 2 —27%. 
 For drinking category deﬁ nition, refer to Methods section. 
 a Age variable centered at 50 years. 
60
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 Figure 1 .  Each column represents a clinical scenario with additive at-
tributes: (A) A 50-year-old man with CP who is non-smoker, has no pain, 
disability/unemployment, or co-morbidities. (B) Subject in A with constant 
mild-to-moderate pain with episodes of severe pain or constant severe pain 
that does not change. (C) Subject in B who is also a current smoker. (D) 
Subject in C with disability/unemployment.
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cantly impact MCS score compared with those patients with no 
pain. Current smoking (3.9 points) and pain-related disability/
unemployment (2.4 points) also signifi cantly reduced the MCS 
score. An interaction was noted between gender and disability/
unemployment—the eff ect of disability/unemployment on MCS 
was an additional 3.7 points lower for women than for men. Oth-
er factors associated with lower MCS scores on the univariable 
analysis were not signifi cant aft er adjusting for other variables 
and were not included in the fi nal regression model. Variables in 
the fi nal multivariable models explained 17.9% of the variance in 
MCS score.
 To illustrate the impact of individual factors and incremental 
eff ect of predictive factors, representative MCS score for a 50-year-
old CP man are shown in  Figure 1 . Progressive addition of select 
attributes, such as constant mild-to-moderate pain with episodes 
of severe pain or constant severe pain, current smoking, and dis-
ability/unemployment, would decrease the MCS score from 49.8 
to 36.6.
 Sensitivity analysis .  Sensitivity analysis aft er excluding patients 
from the original NAPS2 study showed slight diff erences in the 
estimated eff ect sizes but were overall consistent with the main 
analyses (data not shown).
 DISCUSSION
 In this largest prospective study to date, we found that pain—
especially constant, pain-related disability/unemployment, 
current smoking, and concurrent co-morbidities, to have a sig-
nifi cant negative impact on the QOL of CP patients. Interestingly, 
physician-defi ned alcohol etiology, disease duration, pancreatic 
morphology, and prior endoscopic or surgical treatments did not 
independently aff ect QOL. Th ese data underscore the need to bet-
ter understand factors driving pain and to develop eff ective strate-
gies to address them. Facilitating behavioral modifi cation will also 
have an impact on QOL in these patients. As only a fraction of 
variance in PCS and MCS scores was explained by our analyses, 
future studies should focus on identifying other factors aff ecting 
the QOL of CP patients.
 Pain occurs in up to 90% of CP patients, and about half of 
them have constant pain ( 9 ). Although the association of pain 
with poor QOL is consistent across studies ( 3,5–10 ), whether the 
eff ect is greater with severity or temporal nature of pain is debat-
able. A small single-center Polish study of 69 patients revealed 
that pain intensity correlates with QOL scores more oft en than 
frequency ( 8 ). More recently, Olesen  et al. ( 10 ) assessed the asso-
ciation between the intensity and temporal pattern of pain with 
the QOL of 106 CP patients from two tertiary medical centers 
in the Netherlands and Denmark. In addition to measuring pain 
severity by the modifi ed brief pain inventory short form ( 21 ), the 
authors used this scale to indirectly classify pain frequency into 
three patterns: intermittent, constant, and constant with acute 
exacerbations. Aft er adjustment for confounders, they found that 
pain severity but not pain pattern was signifi cantly correlated 
with global health status, all functional subscales, and most symp-
tom subscales.
 In 414 CP patients enrolled in the original NAPS2 study, we 
reported that constant pain was associated with lower physical and 
mental QOL scores when compared with those who had inter-
mittent pain ( 9 ). Th e present study extends those fi ndings using 
multivariable analyses in a larger cohort and provides a numeric 
estimate of the eff ect of each pain type on QOL. We found that, 
compared with those patients with no pain, constant mild-to-
moderate pain with episodes of severe pain or constant severe pain 
to be the strongest predictor of poor physical (10 points reduc-
tion) and mental QOL (6.9 points reduction), followed by constant 
mild-to-moderate pain (5.2 and 6.8 points reduction, respec-
tively). Th e eff ect of constant pain on QOL was statistically sig-
nifi cant, clinically relevant, and independent of other covariates 
such as demographics, risk factors, and co-morbidities. Inter-
mittent severe pain had no eff ect on the mental QOL but had a 
borderline signifi cant eff ect on physical QOL. Th ese data suggest 
that both temporal nature and severity of pain are important to 
consider when designing pain management strategies and clinical 
 Table 3 .  Multivariable regression model showing signiﬁ cant 
determinants for mental quality of life in chronic pancreatitis 
 Variable  Reference 
category 
 Parameter 
estimate 
 s.e.  P -value 
 Intercept  —  49.81  1.4  <0.001 
 Age 50 years a  —  0.04  0.03  0.16 
 Female  Male  −0.3  0.8  0.7 
 Pain 
  Intermittent mild-to-
moderate episodes 
of pain 
 No pain  −1.3  1.6  0.41 
  Intermittent severe 
episodes of pain 
  −0.2  1.4  0.87 
  Constant mild-to-
moderate pain 
  −6.8  1.9  <0.001 
  Constant mild-to-
moderate pain with 
episodes of severe 
pain or constant 
severe pain 
  −6.9  1.4  <0.001 
 Disabled or 
unemployed 
 Not disabled or 
unemployed 
 −2.4  1.1  0.03 
 Smoking status 
 Past  Never smoker  −0.3  1  0.79 
 Current   −3.9  0.9  <0.001 
     
 Liver disease  No liver 
disease 
 −2.4  1.2  0.052 
 Female×disability/
unemployment b 
 —  −3.7  1.6  0.02 
 R 2 =17.9%. 
 a Age variable centered at 50 years. 
 b A signiﬁ cant interaction was found for female gender and disability/unemploy-
ment. 
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management of exocrine insuffi  ciency or diabetes, etc. on QOL. 
We did not fi nd a signifi cant diff erence in QOL based on whether 
a patient had prior pancreatic endotherapy or surgery. Th is 
observation merely represents a cross-sectional assessment and 
does not address the question of whether performance of endo-
therapy or surgery improves QOL. Such a question can best be 
answered by studies specifi cally designed to evaluate changes 
in QOL before and aft er an intervention—in fact, several such 
studies have concluded the benefi t of these interventions on QOL 
( 11–14 ). A previous study of 83 CP patients (87% alcoholic) 
found the QOL to be stable over a 2-year period ( 41 )—however, 
larger studies in patients with diverse etiologies with a longer 
follow-up period are needed to better assess temporal trends and 
determinants of QOL. Second, we excluded 126 patients in the 
original NAPS2 study who did not identify a pain pattern, and 
given the large sample size in the fi nal cohort, we feel the impact 
of excluding these patients is likely small and would not aff ect the 
conclusions. Th ird, recruitment of patients mainly from referral 
centers and under-representation of racial groups (e.g., Hispanics, 
Asians, etc.) despite the multicenter eff ort may limit the general-
izability of our fi ndings.
 Finally, even aft er an exhaustive evaluation of multiple fac-
tors, we only explain 27% variance in physical and 17.9% vari-
ance in mental QOL, leaving several unmeasured variables. 
Future studies should assess the role of factors not included 
in our analyses, examples of which include bowel habits (e.g., 
diarrhea, steatorrhea, opioid-induced constipation), malnutri-
tion (e.g., weight loss, micronutrient defi ciencies, metabolic 
bone disease), psychological factors (e.g., depression, anxiety, 
stress, sleep disturbance, substance abuse), social factors (e.g., 
work absenteeism, fi nancial status, social support), health-care 
utilization (e.g., frequency and duration of hospitalizations), 
adherence to medical care, and genetics. Th e impact of behav-
ioral (e.g., smoking or alcohol cessation strategies, relaxation 
techniques), medical (e.g., narcotics, neuromodulating agents, 
antidepressants, pancreatic enzyme replacement, micronutrient 
supplementation), endoscopic (e.g., pancreatic or biliary stent-
ing, endoscopic shock wave lithotripsy, celiac plexus block) and 
surgical (e.g., drainage and resection techniques, total pancrea-
tectomy and islet auto transplantation) interventions, and phys-
ical therapy needs further assessment. Management of CP by an 
interdisciplinary team with expertise in primary care, behavio-
ral health, gastroenterology, therapeutic endoscopy, pancreatic 
surgery, endocrinology, and radiology has been recommended. 
Th e impact of such an approach on QOL should be empirically 
evaluated.
 In summary, this large multicenter study demonstrated that 
constant pain, pain-related disability/unemployment, current 
smoking, and concurrent co-morbidities signifi cantly impair the 
QOL of CP. Th ese data expand our understanding that both tem-
poral nature and severity of pain are important to consider when 
designing clinical trials in CP. Developing treatment strategies 
aimed to target modifi able factors may help in improving the QOL 
of CP patients. Future research is needed to identify factors that 
were not included in this study.
trials in CP patients. Th e relevance of constant nature of symptoms 
was aptly demonstrated in the classic study of the natural history 
of alcoholic CP by Ammann  et al. , ( 22 ) where the temporal 
nature of pain was the primary determinant for the need for surgi-
cal intervention. Interestingly, constant pain has also been shown 
to have a signifi cant impact on QOL in many other health condi-
tions ( 23–25 ).
 Th e eff ect of smoking on QOL in CP diff ers between stud-
ies. In two Italian studies, current smoking ( 3 ) and the amount 
and duration of smoking did not aff ect QOL ( 7 ). In contrast, 
we previously had shown and this study confi rmed that current 
smoking had a signifi cant impact on both physical and mental 
QOL ( 4 ). Similarly, Han  et al. ( 26 ) reported smokers to have a 
signifi cantly worse physical QOL when compared with non-
smokers. A Polish study found the duration of smoking to be 
associated with lower physical functioning and insomnia and 
the amount of smoking with worse fear of future health ( 8 ). Th e 
mechanism by which smoking has an eff ect on QOL is unclear. 
One possible explanation may be the eff ect of smoking on dis-
ease-related manifestations such as worsening of morphology 
(e.g., calcifi cations, exocrine and/or endocrine function)—how-
ever, it is interesting to note that morphological or functional 
derangements by themselves did not impact QOL. Other pos-
sible explanations would be indirect, similar to the eff ect of cur-
rent smoking on general QOL in conditions related or unrelated 
to smoking ( 27–31 ). Prevalence of aff ective spectrum disorders 
in CP patients is high and patients may smoke to relieve anxi-
ety, depression, or stress that is preexisting or develops aft er 
diagnosis of CP or to cope with the need to abstain from drink-
ing ( 32–35 ). Smoking cessation by counseling and/or pharma-
cological measures should be an important component of the 
management of CP, not only owing to its association with QOL 
but also for its impact on disease progression ( 36,37 ). Although 
smoking cessation strategies show good results in many condi-
tions, its results in CP can be challenging and fail in the majority 
of patients ( 26 ).
 Th e independent eff ect of disability/unemployment on QOL has 
not been adequately studied. We found disability/unemployment 
related to CP to have a signifi cant negative impact on physical 
as well as mental QOL. Wehler  et al. ( 5 ) reported an independ-
ent reduction of PCS score caused by CP-related unemployment 
or early retirement. Disability/unemployment can lead to heavy 
psychological burden, fi nancial distress, and disruption in social 
and family relationships, which can limit the ability to cope with 
the disease ( 38,39 ). Future strategies should focus to prevent work 
disability and to help disabled patients to get back into the labor 
force ( 40 ).
 Strengths of our study include a large, well-phenotyped cohort 
of patients and a comprehensive analysis of multiple relevant var-
iables. Th is approach overcomes important limitations of prior 
work in this area. Our study also has limitations. First, this was 
a one-time assessment of QOL in patients with a chronic condi-
tion. Th erefore, we are unable to evaluate for temporal changes 
in QOL, as well as the direct impact of interventions, such as 
pancreatic endotherapy or surgery, pain management, medical 
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 Study Highlights
 WHAT IS CURRENT KNOWLEDGE 
 ✓  Chronic pancreatitis has a profound effect on quality of 
life. 
 ✓  Factors that determine quality of life in chronic pancreatitis 
patients are not well established. 
 WHAT IS NEW HERE 
 ✓  Constant pain had the most impact on quality of life of 
chronic pancreatitis patients. 
 ✓  Other independent factors were disability/unemployment 
related to pain, current smoking, and co-morbid condi-
tions. 
 ✓  Prior endoscopic or surgical pancreatic interventions had 
no impact on the quality of life. 
 ✓  Alcohol etiology, disease duration, and pancreatic morphol-
ogy had no effect on the quality of life. 
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